two
novel
coronavirus
emerg
human
twentyfirst
centuri
sever
acut
respiratori
syndrom
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
caus
acut
respiratori
distress
syndrom
ard
associ
high
mortal
rate
clinic
approv
vaccin
antivir
drug
avail
either
infect
thu
develop
effect
therapeut
prevent
strategi
readili
appli
new
emerg
strain
research
prioriti
review
describ
emerg
identif
novel
human
coronavirus
past
year
discuss
key
biolog
featur
includ
tropism
receptor
use
summar
approach
develop
broadli
effect
vaccin
wwwnaturecomreviewsmicro
coronavirus
potenti
lethal
pathogen
sever
novel
strain
emerg
identifi
anim
human
popul
past
year
global
sever
acut
respiratori
syndrom
coronaviru
sarscov
epidem
recogn
earli
caus
mortal
infect
individu
depend
age
sarscov
probabl
origin
bat
search
reservoir
result
vast
expans
librari
known
coronavirus
mani
virus
infect
variou
bat
anim
speci
sever
phylogenet
similar
known
pathogen
human
coronavirus
suggest
addit
emerg
event
highli
like
occur
inde
recent
report
confirm
emerg
novel
coronaviru
design
middl
east
respiratori
syndrom
coronaviru
merscov
caus
mortal
patient
seek
medic
attent
transmiss
close
contact
caus
transmiss
cluster
case
sever
countri
includ
saudi
arabia
jordan
qatar
unit
kingdom
bat
speci
implic
reservoir
merscov
speci
distinct
thought
involv
emerg
sarscov
coronavirus
also
major
pathogen
anim
popul
exampl
porcin
epidem
diarrhoea
viru
pedv
relat
certain
bat
alphacoronavirus
fig
major
caus
econom
loss
swine
industri
europ
southeast
asia
detect
us
herd
nation
pork
board
statement
pedv
recent
coronaviru
emerg
event
summar
articl
indic
coronavirus
potenti
rapidli
adapt
stabli
transmit
new
speci
see
box
discuss
structur
protein
coronavirus
observ
pair
appar
extens
zoonot
reservoir
propens
coronavirus
emerg
highli
virul
human
pathogen
spur
develop
anim
model
investig
coronaviru
replic
pathogenesi
vaccin
efficaci
addit
coronaviru
vaccin
histor
exhibit
poor
capac
crossprotect
design
method
gener
safe
effect
vaccin
rapidli
implement
emerg
epidem
high
prioriti
review
summar
human
coronaviru
emerg
event
taken
place
past
decad
highlight
key
biolog
properti
uniqu
coronavirus
discuss
develop
anim
model
character
coronaviru
replic
pathogenesi
transmiss
vaccin
efficaci
examin
variou
strategi
implement
product
safe
effect
coronaviru
vaccin
two
coronavirus
known
caus
human
diseas
human
coronaviru
identifi
caus
compar
mild
common
cold
except
infant
elderli
immunocompromis
symptom
purifi
select
also
call
neg
select
type
natur
select
remov
deleteri
allel
sever
howev
earli
previous
uncharacter
viru
associ
develop
sar
often
progress
sever
lung
diseas
isol
human
infect
patient
exhibit
atyp
pneumonia
character
diffus
alveolar
damag
potenti
progress
acut
respiratori
distress
syndrom
ard
box
sar
first
report
guangdong
provinc
china
diseas
quickli
spread
worldwid
unpreced
global
contain
effort
final
statist
includ
infect
individu
nearli
death
viru
lineag
b
betacoronaviru
eventu
name
sarscov
found
cross
human
zoonot
reservoir
bat
himalayan
palm
civet
paguma
larvata
raccoon
dog
nyctereut
procyonoid
subsequ
sar
epidem
two
coronavirus
capabl
caus
diseas
human
identifi
archiv
nasopharyng
aspir
virus
caus
mild
seriou
lower
respiratori
tract
infect
includ
croup
bronchiol
pneumonia
infant
children
adult
although
precis
diseas
preval
sever
especi
young
still
studi
although
character
virus
carri
recent
molecular
clock
analys
indic
probabl
diverg
nearest
rel
around
year
ago
howev
molecular
clock
analys
period
time
might
vastli
underestim
overestim
mutat
mask
rate
chang
owe
purifi
select
fig
timelin
june
septemb
two
case
sever
infect
anoth
novel
coronaviru
identifi
eastern
mediterranean
region
patient
succumb
sever
respiratori
ill
time
write
case
death
associ
novel
merscov
confirm
us
center
diseas
control
prevent
cdc
merscov
incid
updat
merscov
infect
caus
atyp
pneumonia
ard
case
renal
failur
often
fatal
howev
mortal
rate
yet
accur
estim
owe
small
number
confirm
case
addit
evid
infect
caus
less
sever
ill
cluster
infect
occur
among
famili
hospit
even
asymptomat
full
genom
sequenc
coronavirus
align
phylogenet
compar
three
distinct
phylogenet
group
shown
alphacoronavirus
green
betacoronavirus
blue
gammacoronavirus
orang
taxonom
nomenclatur
replac
former
group
design
respect
deltacoronavirus
newli
character
shown
classic
subgroup
cluster
mark
betacoronavirus
alphacoronavirus
tree
gener
use
maximum
likelihood
phyml
packag
scale
bar
repres
nucleotid
substitut
node
bootstrap
support
label
envelop
protein
spike
protein
posit
reaction
serum
sampl
test
pathogen
exampl
detect
antibodi
viru
epitheli
cell
line
lung
alveoli
type
cell
flat
thin
enabl
effici
ga
exchang
epitheli
cell
line
lung
alveoli
type
ii
cell
round
produc
surfact
process
organ
particularli
wild
anim
becom
ecolog
associ
human
addit
human
infect
high
seroposit
merscov
report
camel
although
exact
role
camel
viru
transmiss
mainten
popul
remain
uncertain
case
sarscov
pathogenesi
elderli
seem
especi
vulner
poor
diseas
outcom
result
merscov
infect
particularli
presenc
comorbid
diabet
cardiac
diseas
hypertens
renal
diseas
merscov
lineag
c
betacoronaviru
phylogenet
distinct
known
human
coronavirus
includ
sarscov
merscov
also
use
receptor
distinct
use
sarscov
human
coronavirus
merscov
use
dipeptidyl
peptidas
wherea
sarscov
shown
use
angiotensinconvert
enzym
differ
receptor
usag
seem
affect
tropism
sarscov
infect
type
pneumocyt
wherea
merscov
infect
type
ii
pneumocyt
noncili
bronchial
cell
tabl
addit
merscov
capabl
animaltohuman
humantohuman
transmiss
evid
show
multipl
animaltohuman
transmiss
event
occur
saudi
arabia
addit
humantohuman
transmiss
suggest
merscov
still
undergo
select
anim
human
host
probabl
continu
viru
firmli
establish
human
furthermor
zoonot
isol
might
relat
merscov
identifi
bat
speci
nativ
arabian
peninsula
mexico
ghana
europ
although
investig
initi
focus
himalayan
palm
civet
raccoon
dog
potenti
reservoir
sarscov
infect
multipl
observ
suggest
palm
civet
opportunist
host
rather
primari
reservoir
sarscovlik
virus
wild
marketplac
civet
disproportion
posit
viral
rna
screen
assay
sampl
isol
civet
show
ongo
select
suggest
viru
still
adapt
civet
rather
persist
equilibrium
host
fact
bioinformat
analysi
suggest
least
three
possibl
transmiss
event
occur
civet
human
first
occur
epidem
indic
presenc
sarscov
antigen
serum
sampl
uninfect
individu
second
occur
main
sar
epidem
third
occur
winter
consist
seri
sporad
infect
addit
molecular
analysi
sampl
taken
healthi
individu
hong
kong
reveal
preval
rate
antibodi
sarsrel
virus
suggest
sarscov
close
ancestor
circul
human
epidem
two
group
independ
report
identif
sarscovrel
rna
sequenc
antisar
nucleocapsid
antibodi
rhinolophu
bat
particularli
rhinolophu
sinicu
rhinolophu
macroti
interestingli
high
antibodi
titr
correl
low
rna
level
suggest
activ
viral
replic
occur
bat
speci
genom
virus
differ
approxim
epidem
sarscov
suggest
virus
increas
homolog
sarscov
capabl
use
human
bat
orthologu
dock
entri
could
exist
bat
speci
span
famili
estim
bat
order
chiroptera
compris
mammalian
speci
dispers
much
globe
probabl
enhanc
potenti
act
reservoir
pathogen
extrem
virul
potenti
lethal
anim
human
includ
sarscov
bat
natur
roost
behaviour
combin
ecolog
pressur
select
synanthropi
brought
bat
closer
human
anim
live
proxim
human
probabl
increas
chanc
battoanim
battohuman
transmiss
fact
scenario
propos
transmiss
sarscovrel
coronavirus
bat
human
bat
roost
near
open
market
sold
civet
china
virus
transmit
civet
via
faecal
andor
oral
shed
human
handl
civet
raw
improperli
cook
civet
meat
thu
complet
transmiss
chain
bat
human
altern
bat
might
directli
transmit
viru
human
coronavirus
envelop
rna
virus
infect
caus
diseas
broad
array
anim
human
viru
particl
rang
nm
diamet
surround
characterist
spikeshap
glycoprotein
shown
figur
coronavirus
contain
largest
singlestrand
positivesens
rna
genom
current
known
rang
nearli
kb
length
wherea
coronavirus
encod
strainspecif
accessori
gene
orf
downstream
replicasetranscriptas
order
essenti
structur
gene
remark
wellconserv
coronavirus
encod
replicasetranscriptas
gene
spike
envelop
membran
nucleocapsid
protein
kda
spike
glycoprotein
mediat
host
cell
attach
entri
util
virusand
hostspecif
cell
receptor
receptorbind
domain
rbd
spike
glycoprotein
poorli
conserv
among
virus
result
host
receptor
usag
vari
viral
genera
speci
variabl
contribut
broad
host
rang
coronavirus
virus
breach
cell
type
tissu
host
speci
barrier
rel
eas
sever
acut
respiratori
syndrom
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
recogn
exopeptidas
receptor
dock
entri
human
coronavirus
use
aminopeptidas
carbohydr
crystal
structur
sarscov
merscov
rbd
complex
correspond
receptor
solv
postentri
event
depend
one
cellular
proteas
cathepsin
human
airway
trypsinlik
proteas
hat
transmembran
proteas
serin
cleav
spike
protein
initi
varieti
conform
chang
import
membran
fusion
entri
wwwnaturecomreviewsmicro
via
shed
incident
coinfect
civet
evid
support
hypothesi
genet
reconstruct
r
sinicu
bat
sarscovrel
coronaviru
abl
infect
primat
cell
mous
cell
express
human
molecul
mice
use
model
sarscov
infect
abl
produc
crossneutr
antibodi
mice
sinc
dozen
previous
unknown
bat
corona
virus
identifi
fact
mani
bat
coronavirus
known
distribut
across
coronavirida
famili
enough
evid
suggest
bat
coronavirus
ancestr
sourc
alphacoronaviru
betacoronaviru
genera
fig
addit
recent
studi
report
transmiss
bat
coronaviru
bat
two
differ
subord
support
hypothesi
bat
coinfect
differ
coronavirus
thu
could
enabl
viral
molecular
recombin
given
two
new
human
coronavirus
might
emerg
bat
shown
replic
new
world
bat
cell
prioriti
basic
research
global
health
prepared
includ
determin
amount
viru
divers
bat
speci
parallel
map
breadth
bat
coronaviru
host
rang
among
differ
bat
anim
speci
addit
sarscov
evid
human
coronavirus
emerg
bat
includ
newli
emerg
merscov
merscovrel
virus
littl
diverg
merscov
identifi
recent
survey
pipistrellu
bat
captur
ghana
europ
bat
sampl
ghana
also
carri
viral
sequenc
phylogenet
similar
viral
sequenc
sampl
north
american
perimyoti
bat
phylogenet
similar
ref
addit
immort
cell
perimyoti
bat
capabl
host
infect
support
hypothesi
bat
serv
reservoir
also
revers
transmiss
conduit
clearli
substanti
evid
broad
array
coronavirus
persist
bat
virus
capac
recombin
emerg
novel
anim
human
pathogen
inde
merscov
close
relat
tylonycteri
bat
coronaviru
pipistrellu
bat
coronaviru
three
virus
probabl
emerg
common
ancestor
sever
centuri
ago
addit
mani
polymorph
detect
spike
protein
sequenc
suggest
viru
extens
bat
coronavirus
capabl
gener
mutant
occupi
new
ecolog
nich
encount
novel
host
continu
emerg
virul
human
coronavirus
emphas
need
anim
model
studi
viral
replic
pathogenesi
transmiss
thu
far
work
larg
focus
sarscov
infect
sarscov
replic
report
mice
hamster
cat
civet
primat
sever
diseas
symptom
observ
age
anim
merscov
broad
host
rang
vitro
provid
promis
develop
small
anim
model
human
diseas
near
futur
howev
function
small
anim
model
merscov
replic
pathogenesi
yet
character
report
possibl
ongo
select
receptorbind
sequenc
spike
protein
sequenc
import
host
specif
might
contribut
limit
inocul
rhesu
macaqu
halfmaxim
tissu
cultur
infecti
dose
tcid
merscov
isol
result
transient
mildtomoder
clinic
diseas
includ
local
widespread
pneumonia
howev
lack
small
anim
model
clearli
major
obstacl
further
understand
viral
pathogenesi
test
vaccin
therapeut
epidem
sarscov
strain
isol
human
encod
receptorbind
domain
rbd
interact
well
human
strain
particularli
sarscov
urbani
capabl
interact
mous
orthologu
replic
mous
lung
small
intestin
diseas
limit
mild
respiratori
symptom
minim
weight
loss
howev
passag
sarscov
urbani
balbc
mice
produc
mouseadapt
variant
sarscov
sarscov
sarscov
caus
sever
lethal
respiratori
diseas
close
resembl
clinic
ill
observ
patient
lead
pneumon
acut
lung
injuri
ali
acut
respiratori
distress
syndrom
ard
main
caus
respiratori
failur
result
high
morbid
mortal
infect
involv
respiratori
virus
influenza
sever
acut
respiratori
syndrom
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
radiolog
examin
sarscovand
merscovinfect
patient
reveal
atyp
pneumonia
tissu
level
increas
permeabl
alveolarcapillari
interfac
result
pulmonari
oedema
hypoxia
type
ii
pneumocyt
hyperplasia
cellular
infiltr
particularli
neutrophil
influx
runaway
immun
respons
character
upregul
proinflammatori
cytokin
particularli
cxcchemokin
ligand
ccchemokin
ligand
stage
diseas
gener
follow
increas
fibroprolifer
hyalin
membran
format
depend
patient
gross
patholog
chang
may
progress
resolv
ard
occur
approxim
sarscov
case
note
merscov
case
report
howev
incid
extrem
agedepend
case
sarscov
infect
older
patient
disproportion
affect
mortal
among
patient
popul
exceed
epidem
among
sarscovinfect
patient
develop
ard
need
mechan
ventil
strong
indic
high
risk
mortal
although
anim
model
fulli
recapitul
symptom
profil
observ
human
infect
sarscov
report
note
presenc
lung
injuri
resembl
ard
includ
mouseadapt
sarscovinfect
signal
transduc
activ
transcript
knockout
mice
sarscovinfect
african
green
monkey
lesser
extent
cynomolgu
macaqu
system
biolog
studi
begun
associ
diseas
host
genet
implic
urokinas
pathway
along
woundrepair
pathway
develop
sever
sarscov
diseas
outcom
ard
pathway
includ
diffus
alveolar
damag
ali
mutagenesi
mediat
transcript
activatorlik
effector
nucleas
talen
involv
use
seri
tal
effector
dnabind
repeat
fuse
fok
ispecif
cleavag
domain
enabl
sitespecif
dna
doublestrand
break
nonhomolog
end
join
repair
result
hybrid
gene
construct
cluster
regularli
interspac
short
palindrom
repeat
crispr
consist
multipl
short
conserv
nucleotid
repeat
function
bacteri
immun
system
resist
incorpor
exogen
genet
element
mutagenesi
crisprca
crisprassoci
system
target
foreign
dna
short
complementari
singlestrand
rna
direct
nucleas
target
dna
caus
doublestrand
break
result
silenc
dna
sequenc
diffus
alveolar
damag
young
mice
adapt
requir
mutat
focus
specif
mutat
site
spike
membran
protein
take
approxim
passag
howev
age
mice
mouseadapt
strain
emerg
within
five
passag
defin
fewer
mutat
occur
variou
locat
across
genom
sarscov
mouseadapt
strain
significantli
pathogen
age
anim
shown
reduct
median
lethal
dose
valu
increas
clinic
diseas
sever
extens
ardsassoci
patholog
lesion
increas
mortal
viraemia
rare
transient
mice
common
longlast
patient
subleth
infect
mice
develop
neutral
antibodi
respons
passiv
transfer
sera
mice
protect
recipi
subsequ
lethal
challeng
observ
reflect
probabl
occur
infect
human
epidem
cohort
studi
convalesc
human
sampl
posit
cell
respons
cell
respons
frequent
cell
respons
possess
strongli
neutral
antibodi
cell
epitop
identifi
spike
protein
mous
strain
also
suscept
infect
sarscov
sarscov
mouseadapt
strain
notabl
mice
mice
breadth
suscept
facilit
use
genet
knockout
transgen
anim
relev
transgen
knockout
line
avail
background
exampl
myeloid
differenti
primari
respons
knockout
signal
transduc
activ
transcript
knockout
anim
defect
innat
immun
develop
sever
diseas
weight
loss
pneumon
bronchiol
die
within
day
infect
anim
death
follow
brief
convalesc
period
resurg
anim
inflammatori
respons
contrast
recombin
activ
gene
rag
knockout
sever
combin
immunodefici
scid
mice
defect
adapt
immun
becom
persist
infect
sarscov
inocul
maintain
viral
titr
least
day
infect
evid
clinic
diseas
cours
entir
infect
probabl
owe
lack
inflammatori
respons
would
normal
occur
result
lymphocyt
recruit
sarscov
anim
model
syrian
golden
chines
hamster
also
evalu
model
sarscov
diseas
infect
anim
develop
pneumon
inflamm
immun
cell
infiltr
although
sign
clinic
ill
necessarili
accompani
lung
patholog
contrast
mice
hamster
experi
transient
viraemia
becom
less
activ
addit
viru
detect
spleen
liver
although
associ
inflamm
organ
similarli
mice
hamster
also
develop
protect
neutral
antibodi
respons
subsequ
sarscov
challeng
reagent
measur
immun
respons
hamster
improv
still
limit
avail
genet
defin
anim
refin
immunolog
cellular
marker
hamster
model
talenmedi
mutagenesi
crisprcasmedi
mutagenesi
zygot
might
enabl
develop
genet
defin
hamster
atyp
model
speci
pathogenesi
research
ferret
support
sarscov
replic
upper
lower
respiratori
tract
howev
studi
yield
variabl
result
term
sign
infect
multifoc
lesion
develop
lung
surfac
area
detect
gross
patholog
analysi
clinic
symptom
differ
studi
fever
report
sarscovinfect
ferret
addit
nasal
discharg
sneez
viru
shed
ferret
anim
regularli
develop
fever
infect
sarscov
symptom
hallmark
human
infect
ferret
evalu
model
studi
sarscov
transmiss
use
might
provid
interest
inform
genet
basi
superspread
event
observ
epidem
ferret
human
molecul
probabl
requir
differ
mutat
sarscov
rbd
optim
interact
occur
probabl
transmissionevolv
ferretadapt
strain
would
effici
replic
ferret
less
human
howev
studi
might
highlight
residu
region
role
transmiss
alter
host
specif
sarscov
also
serial
passag
young
rat
yield
viru
capabl
enhanc
replic
limit
pathogenesi
young
rat
sever
clinic
diseas
adult
rat
sequenc
analysi
adapt
mutant
show
substitut
spike
protein
vitro
passag
sarscov
chines
hamster
ovari
cho
cell
express
rat
yield
variant
encod
substitut
spike
protein
sequenc
analysi
ratadapt
variant
might
help
identifi
interest
genet
correl
serial
passag
mous
rat
virus
multipl
nonhuman
primat
nhp
suscept
sarscov
infect
includ
rhesu
macaqu
cynomolgu
macaqu
marmoset
african
green
monkey
clinic
symptom
patholog
vari
speci
nhp
support
infect
show
evid
sarscov
replic
lung
tcid
titr
lung
shed
respiratori
secret
primat
model
develop
histopatholog
chang
show
evid
pneumocyt
infect
degre
diffus
alveolar
damag
diseas
outcom
seem
sever
age
macaqu
reflect
human
diseas
outcom
human
increas
viru
replic
increas
lung
patholog
note
primat
infect
wildtyp
sarscov
compar
anim
model
except
mice
infect
mouseadapt
sarscov
vaccin
candid
evalu
nhp
probabl
owe
cost
challeng
achiev
statist
signific
sampl
size
nhp
studi
current
approv
antivir
treatment
vaccin
human
coronaviru
infect
includ
sarscov
merscov
studi
describ
smallmolecul
inhibitor
potenti
control
sarscov
infect
vitro
studi
report
viru
partial
ribavirin
interferon
sensit
high
dose
clinic
manag
sever
infect
mostli
occur
peopl
infect
sarscov
merscov
limit
support
palli
care
thu
develop
safe
stabl
vaccin
necessari
virus
rise
rapidli
heterogen
zoonot
pool
vaccin
would
ideal
broadspectrum
rapidli
adapt
new
coronavirus
particular
import
protect
elderli
might
disproportion
suscept
sever
diseas
sarscov
merscov
infect
support
hypothesi
median
age
mersaffect
patient
experi
diseas
sever
enough
requir
medic
attent
current
year
age
rang
month
year
merscov
incid
updat
addit
case
sarscov
administr
inactiv
vaccin
without
adjuv
shown
protect
viral
replic
vaccin
sarscov
challeng
primat
ferret
report
favour
helper
h
cell
respons
result
product
subsequ
inflammatori
patholog
rather
macrophagedriven
clearanc
observ
typic
antivir
h
respons
one
particular
inactiv
sarscov
vaccin
doubleinactiv
vaccin
div
use
alum
adjuv
protect
challeng
homolog
viru
howev
induc
eosinophilia
h
cell
immun
patholog
poor
protect
challeng
heterolog
viru
type
respons
note
inactiv
vector
dna
vaccin
see
respiratori
syncyti
viru
eosinophil
infiltr
associ
increas
mortal
exacerb
lung
diseas
eosinophilia
observ
sarscovvaccin
anim
agedepend
might
promot
hypersensit
presenc
inflammatori
h
cellskew
immun
respons
result
use
alon
vaccin
use
nucleocapsid
protein
might
gener
protect
respons
vaccin
use
nucleocapsid
protein
could
result
delayedtyp
hypersensit
spike
nucleocapsid
protein
cov
coronaviru
h
helper
vrp
viruslik
particl
encod
compon
requir
mediat
replic
genom
encod
gene
necessari
product
new
virion
viral
replicon
particl
typic
gener
cotransfect
replicon
genom
helper
cassett
encod
structur
compon
enabl
singl
round
replic
particl
product
occur
respons
enhanc
age
anim
neutrophilia
inactiv
sarscov
vaccin
administ
human
vaccin
well
toler
induc
product
neutral
antibodi
although
particip
rel
young
age
rang
year
lung
patholog
assess
addit
absenc
natur
challeng
data
vaccin
efficaci
avail
liveattenu
vaccin
produc
reduc
elimin
virul
live
viru
typic
use
chemicaldriven
sitedirect
mutagenesi
thu
viru
capabl
product
infect
result
diseas
either
diminish
elimin
liveattenu
vaccin
elicit
innat
adapt
immun
respons
protect
lifelong
addit
product
inexpens
develop
revers
genet
coronavirus
particularli
sarscov
greatli
simplifi
investig
attenuationassoci
allel
resist
revers
cell
cultur
mice
evalu
efficaci
attenu
virus
vaccin
candid
envelop
protein
involv
viral
morphogenesi
intracellular
traffick
bud
might
possess
ion
channel
activ
dispens
sarscov
product
howev
replic
attenu
sarscov
lack
protein
sarscov
lack
envelop
protein
initi
construct
wildtyp
rather
mouseadapt
backbon
protect
challeng
hamster
partial
protect
mice
transgen
express
human
molecul
delet
envelop
protein
engin
backbon
elicit
higher
titr
neutral
antibodi
protect
challeng
age
mice
improv
vaccin
efficaci
probabl
facilit
logincreas
replic
mouseadapt
strain
compar
wildtyp
viru
mice
coronavirus
encod
exonucleas
exon
nonstructur
protein
code
region
exon
shown
mediat
proofread
activ
viral
rnadepend
rna
polymeras
inactiv
exon
sarscov
yield
viabl
replicationattenu
viru
accumul
mutat
passag
gener
background
sarscov
viru
attenu
growth
pathogenesi
young
age
immunocompromis
mice
fulli
protect
lethal
challeng
elicit
high
level
neutral
antibodi
even
low
vaccin
dose
moreov
sarscov
stabl
term
replic
resist
revers
shortand
longterm
passag
high
resist
revers
virul
vitro
vivo
might
due
increas
mutat
frequenc
like
continu
introduc
attenu
andor
neutral
mutat
discourag
andor
prohibit
primari
site
origin
mutat
secondari
site
origin
mutat
revers
virul
particular
advantag
approach
involv
conserv
allel
envelop
exon
asid
effect
replic
efficaci
mous
model
test
conserv
allel
make
prime
candid
rapid
gener
new
vaccin
genom
sequenc
novel
emerg
coronaviru
merscov
known
work
focu
stabil
attenu
background
ensur
remain
resist
primari
secondari
revers
virul
recombin
virul
coronavirus
exampl
coronavirus
possess
network
fairli
wellconserv
transcript
regulatori
sequenc
trss
essenti
product
subgenom
mrna
chang
tr
consensu
yield
viabl
virus
reduc
capac
recombin
coronavirus
method
show
great
promis
render
vaccin
candid
refractori
recombin
natur
occur
virul
coronavirus
enhanc
safeti
use
genet
engin
coronavirus
live
vaccin
recent
develop
merscov
revers
genet
system
approach
also
test
newest
emerg
coronaviru
vaccin
approach
viralvector
vaccin
function
viral
gene
deliveri
system
reli
host
viral
genom
exampl
adenoviru
typic
lack
genet
compon
necessari
produc
new
virion
encod
antigen
compon
viru
interest
elicit
immun
respons
viralvector
vaccin
persist
host
genet
materi
directli
infect
antigenpres
cell
strong
inher
adjuv
activ
effici
induc
innat
b
celland
cellmedi
immun
respons
adenoviru
vector
express
sarscov
spike
nucleocapsid
protein
immunodomin
coronaviru
protein
yield
vari
result
depend
prepar
rout
administr
anim
model
use
howev
challeng
experi
alway
perform
although
intramuscular
vaccin
induc
high
serum
titr
neutral
antibodi
intranas
inocul
effect
prevent
replic
challeng
viru
suggest
intranas
rout
effici
induc
mucos
immun
sidebysid
comparison
inactiv
viru
adenovirusvector
vaccin
produc
significantli
lower
titr
neutral
antibodi
protect
subsequ
challeng
although
protect
inactiv
viru
venezuelan
equin
enceph
viru
vee
viral
replicon
particl
vrp
also
use
express
sarscov
spike
nucleocapsid
protein
spikeexpress
vrp
vrp
vaccin
protect
lethal
homolog
challeng
young
age
balbc
mice
challeng
lethal
viru
express
heterolog
spike
protein
young
mice
protect
short
time
viral
vector
use
spike
protein
includ
poxviru
parainfluenza
viru
rabi
viru
vesicular
stomat
viru
confirm
delayedtyp
hypersensit
also
call
type
iv
hypersensit
cellmedi
immunolog
respons
rather
antibodymedi
respons
immun
reaction
develop
hour
exposur
immunogen
product
neutral
antibodi
demonstr
protect
convers
vaccin
vrp
construct
express
sarscov
nucleocapsid
protein
result
h
cellskew
immun
respons
immun
patholog
lung
protect
homolog
heterolog
challeng
similarli
vector
vaccin
subunit
vaccin
util
antigen
compon
viru
interest
contrast
vector
vaccin
propag
organ
grown
laboratori
rather
vaccine
antigen
compon
harvest
use
vaccin
sarscov
subunit
vaccin
contain
either
spike
protein
fragment
consist
amino
acid
nucleocapsid
protein
crystal
structur
sarscov
merscov
spike
protein
rbd
solv
complex
correspond
receptor
interact
residu
map
domain
obviou
target
subunit
vaccin
design
addit
subunit
spike
vaccin
produc
higher
neutral
antibodi
titr
liveattenu
sarscov
poxviru
spike
protein
dna
spike
protein
dna
vaccin
subunit
nucleocapsid
vaccin
induc
high
level
b
celland
cellmedi
immun
respons
howev
vivo
challeng
experi
yet
perform
dna
vaccin
consist
dna
encod
viral
antigen
compon
directli
inject
otherwis
inocul
vaccine
vector
subunit
vaccin
dna
vaccin
also
use
spike
peptid
elicit
high
titr
neutral
antibodi
interestingli
dna
vaccin
use
combin
inactiv
vaccin
cellular
immun
respons
h
celldirect
wherea
vaccin
inactiv
viru
alon
induc
h
cell
respons
similarli
viral
nucleocapsid
protein
vector
vaccin
dna
vaccin
encod
nucleocapsid
protein
induc
strong
cellmedi
immun
protect
hightitr
challeng
addit
unlik
spike
protein
vaccin
dnanucleocapsid
dnan
vaccin
induc
delayedtyp
hypersensit
even
absenc
antibodi
respons
importantli
sub
unit
dna
vaccin
rigor
test
either
young
age
anim
lethalchalleng
model
true
vivo
efficaci
current
unknown
emerg
sarscov
taught
us
mani
lesson
zoonot
reservoir
import
identifi
anim
model
recapitul
variou
aspect
human
diseas
determin
vaccin
efficaci
safeti
knowledg
appli
recent
emerg
merscov
human
popul
strikingli
high
morbid
mortal
rate
hospit
individu
clear
merscov
potenti
profound
impact
human
popul
howev
low
penetr
thu
far
suggest
viru
might
ultim
fail
develop
nich
human
might
still
adapt
human
host
worst
effect
yet
come
studi
sarscov
suggest
merscov
research
focu
establish
anim
model
recapitul
replic
pathogenesi
transmiss
human
prioriti
develop
treatment
prevent
viralinduc
immun
patholog
particularli
elderli
furthermor
vaccin
target
conserv
allel
provid
broad
protect
strain
close
distantli
relat
vaccin
strain
develop
one
particular
concern
possibl
merscov
vaccin
elicit
h
cell
immun
patholog
seen
inactiv
vector
dna
sarscov
vaccin
liveattenu
vaccin
vaccin
combin
exampl
inactiv
viru
combin
dna
vaccin
seem
induc
immun
phenomenon
thu
approach
might
hold
promis
develop
success
vaccin
strategi
particularli
older
popul
adjuv
promot
robust
h
cell
respons
also
evalu
rigor
model
second
concern
sarscov
escap
neutral
driven
spike
protein
variabl
thu
spikedepend
vaccin
strategi
might
requir
multival
approach
merscov
natur
variat
merscov
spike
glycoprotein
mostli
unknown
thu
essenti
natur
isol
recov
sequenc
human
reservoir
speci
focus
prioriti
help
combat
emerg
merscov
also
increas
prepared
futur
coronaviru
emerg
event
origin
vast
mutabl
zoonot
reservoir
heterolog
sarscovand
merscovrel
isol
encod
even
minut
variat
spike
protein
import
reagent
evalu
vaccin
efficaci
futur
emerg
strain
coronaviru
phylogeni
demonstr
incred
divers
antigen
variant
lead
limit
crossprotect
infect
differ
strain
even
within
phylogenet
subclust
consequ
risk
introduc
novel
coronavirus
naiv
human
anim
popul
remain
high
despit
antigen
breadth
reveal
alphacoronavirus
betacoronavirus
often
use
receptor
orthologu
andor
recogn
carbohydr
crossspeci
transmiss
given
larg
number
bat
speci
ecolog
enabl
potenti
pathogen
spread
bat
popul
number
bat
coronavirus
might
natur
abl
recogn
human
orthologu
receptor
dock
entri
recent
studi
analys
viral
biodivers
fli
fox
pteropu
giganteu
support
hypothesi
coronaviru
speci
among
sever
potenti
novel
viral
speci
identifi
pcr
assay
moreov
phylogeni
cornonavirus
appear
human
popul
indic
acceler
pattern
emerg
diseas
outbreak
zoonot
sourc
molecular
clock
analys
estim
date
emerg
year
ago
year
ago
year
ago
pedv
year
ago
respiratori
bovin
cov
rbcov
year
ago
fig
demonstr
potenti
paradigm
shift
relationship
coronavirus
domest
anim
human
host
bat
coronavirus
probabl
evolv
transmit
close
proxim
broader
host
tropism
result
larg
multi
speci
bat
popul
exist
across
much
globe
pattern
transmiss
facilit
spread
coronavirus
host
exampl
intens
farmmanag
practic
result
thousand
anim
hous
togeth
close
environ
human
popul
densiti
increas
past
year
encroach
wild
anim
habitat
addit
averag
age
human
popul
increas
proport
immunocompromis
individu
suscept
sever
lung
infect
condit
provid
vulner
host
sever
diseas
anim
model
repres
process
human
lead
rapid
vivo
evolut
virul
transmiss
fig
fact
earli
case
sarscov
merscov
describ
elderli
aros
close
contact
hospit
famili
set
emerg
virul
sarscov
background
older
host
could
requir
fewer
mutat
less
passag
requir
young
host
moreov
close
proxim
import
determin
effici
coronaviru
crossspeci
transmiss
dissemin
possibl
current
project
ecolog
demograph
condit
approach
critic
point
coronavirida
famili
pois
excel
condit
colon
grow
nich
hypothes
correct
acceler
transmiss
bat
anim
coronavirus
human
expect
continu
possibl
escal
public
health
author
prepar
develop
broadli
applic
platform
strategi
rapid
diagnosi
contain
treatment
vaccin
emerg
coronaviru
infect
warn
twice
recent
year
belief
coronavirus
highli
vulner
public
health
intervent
strategi
support
increas
incid
coronaviru
emerg
livestock
anim
popul
identif
novel
coronavirus
reservoir
speci
despit
applic
widespread
diseas
manag
practic
intervent
strategi
recent
identif
bat
sarslik
coronavirus
chines
horsesho
bat
capabl
use
bat
human
receptor
entri
strongli
support
argument
sarscov
emerg
human
infect
directli
bat
reservoir
data
emphas
import
survey
synanthrop
wildlif
popul
potenti
zoonot
candid
